Clinical Trial Update: Combination of Capecitabine and Oxaliplatin in Patients With Relapsed or Refractory Gastric Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of capecitabine and oxaliplatin in patients with relapsed or refractory gastric cancer has been suspended, per the la…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Capecitabine (Xeloda) (Capecitabine)
• Oxaliplatin (Eloxatin) (oxaliplatin)

Snippet

Sponsor: Fudan University | Conditions: Gastric Cancer | Phase 2 | Status: SUSPENDED